MAP3K7 antibody (AA 250-300)
Quick Overview for MAP3K7 antibody (AA 250-300) (ABIN7452450)
Target
See all MAP3K7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 250-300
-
Purpose
- Rabbit anti-TAK1 Antibody, Affinity Purified
-
Predicted Reactivity
- Mouse,Rat,Bovine,Orangutan
-
Purification
- Affinity Purified
-
Immunogen
- between AA 250 and 300
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IP: 2 - 5 μg/mg lysate
WB: Not recommended. Use rabbit anti-TAK1 antibody ABIN7452087.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Expiry Date
- 12 months
-
-
- MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7))
-
Alternative Name
- TAK1
-
Background
- Background: TAK1 (TGF-beta activated kinase 1) is also called mitogen-activated protein kinase kinase kinase 7 (MAP3K7). TAK1 is a serine/threonine protein kinase that mediates signals transduced by proinflammatory cytokines such as TGF-beta, tumor necrosis factor (TNF), interleukin-1 (IL-1) and wnt family ligands. TAK1 transduces signals by stimulating a MAPK pathway that ultimately stimulates JNK (c-terminal jun kinase) and p38 MAPKs. TAK1 is also an activator of the Ikappa B kinase that leads to the activation of NFkappa-B.
-
Gene ID
- 6885
-
NCBI Accession
- NP_663304
-
UniProt
- O43318
-
Pathways
- NF-kappaB Signaling, TCR Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Toll-Like Receptors Cascades, BCR Signaling, Ubiquitin Proteasome Pathway
Target
-